Literature DB >> 1839146

Inhibition of dorsal raphe cell firing by MDL 73005EF, a novel 5-HT1A receptor ligand.

J S Sprouse1.   

Abstract

The effect of a novel ligand for the 5-HT1A receptor subtype, MDL 73005EF, on the firing rate of serotonergic dorsal raphe neurons was assessed in rat midbrain slices maintained in vitro. Superfusion with MDL 73005EF inhibited neuronal firing in a concentration-dependent manner. Based upon IC50 values, MDL 73005EF was equipotent with buspirone (129 +/- 34 vs. 97 +/- 8 nM, respectively) but significantly less potent than 8-OH-DPAT (8-hydroxy-2(di-n-propylamino)tetralin; 7 +/- 2 nM). Pretreatment with (-)-propranolol (1 microM), a mixed 5-HT1A/B receptor antagonist, blocked by 50% the inhibition of unit activity elicited by MDL 73005EF. Taken together, these data suggest that MDL 73005EF is an agonist at the somatodendritic autoreceptor on dorsal raphe neurons, a 5-HT1A receptor which regulates in part the pacemaker activity of these cells. The results are discussed in the context of receptor reserve, recently proposed to explain apparent discrepancies in the actions of agonists at pre- and postsynaptic 5-HT1A sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839146     DOI: 10.1016/0014-2999(91)90340-v

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors.

Authors:  Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2007-05-08       Impact factor: 3.252

2.  Infralimbic and dorsal raphé microinjection of the 5-HT(1B) receptor agonist CP-93,129: attenuation of aggressive behavior in CFW male mice.

Authors:  S Faccidomo; I M H Quadros; A Takahashi; E W Fish; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2012-01-07       Impact factor: 4.530

3.  BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.

Authors:  F Borsini; A Ceci; G Bietti; A Donetti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

4.  Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro.

Authors:  P Van den Hooff; M Galvan
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

5.  Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist.

Authors:  C Defraiteur; A Plenevaux; J Scuvée-Moreau; N Rouchet; D Goblet; A Luxen; V Seutin
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

6.  Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.

Authors:  M Suzuki; T Matsuda; S Asano; P Somboonthum; K Takuma; A Baba
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.